-
1
-
-
1542358915
-
Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers
-
DOI 10.1373/clinchem.2003.026849
-
Hafner C, Schmitz G, Meyer S, et al. Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers[J]. Clin Chem, 2004,50(3) : 490-499. (Pubitemid 38297297)
-
(2004)
Clinical Chemistry
, vol.50
, Issue.3
, pp. 490-499
-
-
Hafner, C.1
Schmitz, G.2
Meyer, S.3
Bataille, F.4
Hau, P.5
Langmann, T.6
Dietmaier, W.7
Landthaler, M.8
Vogt, T.9
-
2
-
-
24644498612
-
Downregulation of EphA7 by hypermethylation in colorectal cancer
-
DOI 10.1038/sj.onc.1208720, PII 1208720
-
Wang J, Kataoka H, Suzuki M, et al. Downregulation of EphA7 by hypermethylation in colorectal cancer[J]. Oncogene, 2005, 24(36) : 5637-5647. (Pubitemid 43119357)
-
(2005)
Oncogene
, vol.24
, Issue.36
, pp. 5637-5647
-
-
Wang, J.1
Kataoka, H.2
Suzuki, M.3
Sato, N.4
Nakamura, R.5
Tao, H.6
Maruyama, K.7
Isogaki, J.8
Kanaoka, S.9
Ihara, M.10
Tanaka, M.11
Kanamori, M.12
Nakamura, T.13
Shinmura, K.14
Sugimura, H.15
-
3
-
-
35348908291
-
Differential expression of EphA7 receptor tyrosine kinase in gastric carcinoma
-
DOI 10.1016/j.humpath.2007.01.030, PII S0046817707001608
-
Wang J, Li G, Ma H, et al. Differential expression of EphA7 receptor tyrosine kinase in gastric carcinoma[J]. Hum Pathol, 2007,38(11) : 1649-1656. (Pubitemid 47589087)
-
(2007)
Human Pathology
, vol.38
, Issue.11
, pp. 1649-1656
-
-
Wang, J.1
Li, G.2
Ma, H.3
Bao, Y.4
Wang, X.5
Zhou, H.6
Sheng, Z.7
Sugimura, H.8
Jin, J.9
Zhou, X.10
-
4
-
-
42249088607
-
Increased expression of EphA7 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients[J]
-
Wang L F, Fokas E, Juricko J, et al. Increased expression of EphA7 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients[J]. BMC Cancer,2008, 8(3) : 79.
-
(2008)
BMC Cancer
, vol.8
, Issue.3
, pp. 79
-
-
Wang, L.F.1
Fokas, E.2
Juricko, J.3
-
5
-
-
58149402919
-
Aberrant methylation of E-phA7 in human prostate cancer and its relation to clinopathologic features[J]
-
Guan M, Xu C, Zhang F, et al. Aberrant methylation of E-phA7 in human prostate cancer and its relation to clinopathologic features[J]. Int J Cancer,2009,124(1) : 88-94.
-
(2009)
Int J Cancer
, vol.124
, Issue.1
, pp. 88-94
-
-
Guan, M.1
Xu, C.2
Zhang, F.3
-
6
-
-
77955713537
-
Clinical significance of ephrin(eph)-Al, -A2,-A4,-A5 and -A7 receptors in pancreatic ductal adenocarcinoma [J]
-
Giaqinis C, Tsourouflis G, Zizi-serbetzoglou A, et al. Clinical significance of ephrin(eph)-Al, -A2,-A4,-A5 and -A7 receptors in pancreatic ductal adenocarcinoma [J]. Pathol Oncol Res,2010,16(2) : 267-276.
-
(2010)
Pathol Oncol Res
, vol.16
, Issue.2
, pp. 267-276
-
-
Giaqinis, C.1
Tsourouflis, G.2
Zizi-serbetzoglou, A.3
-
7
-
-
77149162009
-
Secreted form of EphA7 in lung cancer[J]
-
Tsuboi M, Mori H, Bunai T, et al. Secreted form of EphA7 in lung cancer[J]. Int J Oncol,2010,36(3) : 635-640.
-
(2010)
Int J Oncol
, vol.36
, Issue.3
, pp. 635-640
-
-
Tsuboi, M.1
Mori, H.2
Bunai, T.3
-
8
-
-
1842634484
-
Metadherin, a cell surface protein in breast tumors that mediates lung metastasis
-
DOI 10.1016/S1535-6108(04)00079-0, PII S1535610804000790
-
Brown D M, Ruoslahti E. Metadherin, a cell surface protein in breast tumors that mediates lung metastasis [J]. Cancer Cell, 2004,5(4) : 365-374. (Pubitemid 38482072)
-
(2004)
Cancer Cell
, vol.5
, Issue.4
, pp. 365-374
-
-
Brown, D.M.1
Ruoslahti, E.2
-
9
-
-
57849134562
-
MTDH activationby by 8q22 genomic gain promotes chemoresistance and metastasis of poorprognosis breast cancerfj
-
Hu G, Chong P A, Yang Q, et al. MTDH activationby by 8q22 genomic gain promotes chemoresistance and metastasis of poorprognosis breast cancerfj]. Cancer Cell, 2009,15 (1) : 1-2.
-
(2009)
Cancer Cell
, vol.15
, Issue.1
, pp. 1-2
-
-
Hu, G.1
Chong, P.A.2
Yang, Q.3
-
10
-
-
68049111481
-
Metadherin as a link between metastasis and chemoresistance[J]
-
Wei Y, Hu G, Kang Y. Metadherin as a link between metastasis and chemoresistance[J]. Cell Cycle,2009,8 (14) : 2132-2133.
-
(2009)
Cell Cycle
, vol.8
, Issue.14
, pp. 2132-2133
-
-
Wei, Y.1
Hu, G.2
Kang, Y.3
-
11
-
-
77953624680
-
Immunohistochemical analysis of metadherin in proliferative and cancerous breast tissue [J]
-
Su P, Zhang Q. Immunohistochemical analysis of metadherin in proliferative and cancerous breast tissue [J]. Diagn Pathol, 2010,5(5) : 38.
-
(2010)
Diagn Pathol
, vol.5
, Issue.5
, pp. 38
-
-
Su, P.1
Zhang, Q.2
-
12
-
-
65549113479
-
Overexpression of astrocyte elevated gene-1 (AEG-I) is associated with esophageal squamous cell carcinoma (ESCC) progression and pathogenesis[J]
-
Yu C, Chen K, Zheng H, et al. Overexpression of astrocyte elevated gene-1 (AEG-I) is associated with esophageal squamous cell carcinoma (ESCC) progression and pathogenesis[J]. Carcinogenesis, 2009,30(5) : 894-901.
-
(2009)
Carcinogenesis
, vol.30
, Issue.5
, pp. 894-901
-
-
Yu, C.1
Chen, K.2
Zheng, H.3
-
13
-
-
67650076377
-
Astrocyte elevated gene-1 contributes to the pathogenesis of neuroblastoma [J]
-
Lee S G, Jeon H Y, Su Z Z, et al. Astrocyte elevated gene-1 contributes to the pathogenesis of neuroblastoma [J]. Oncogene, 2009,28 (26) : 2476-2484.
-
(2009)
Oncogene
, vol.28
, Issue.26
, pp. 2476-2484
-
-
Lee, S.G.1
Jeon, H.Y.2
Su, Z.Z.3
-
14
-
-
65649143486
-
Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression [J]
-
Yoo B K, Emdad L, Su Z Z, et al. Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression [J]. Clin Invest,2009,119(3) : 465-477.
-
(2009)
Clin Invest
, vol.119
, Issue.3
, pp. 465-477
-
-
Yoo, B.K.1
Emdad, L.2
Su, Z.Z.3
-
15
-
-
32944459561
-
Activation of the nuclear factor kappa B pathway by astrocyte elevated gene-1: Implications for tumor progression and metastasis [J]
-
Emdad L, Sarkar D, Su Z Z, et al. Activation of the nuclear factor kappa B pathway by astrocyte elevated gene-1 : implications for tumor progression and metastasis [J]. Cancer Res, 2006,66(3) ¡1509-1516.
-
(2006)
Cancer Res
, vol.66
, Issue.3
, pp. 1509-1516
-
-
Emdad, L.1
Sarkar, D.2
Su, Z.Z.3
-
16
-
-
33745938939
-
Overexpression of Eph and ephrin genes in advanced ovarian cancer, ephrin gene expression correlates with shortened survival [J]
-
Herath N I, Spanevelb M D, Sabesan S, et al. Overexpression of Eph and ephrin genes in advanced ovarian cancer, ephrin gene expression correlates with shortened survival [J]. BMC Cancer,2006,6(6): 144.
-
(2006)
BMC Cancer
, vol.6
, Issue.6
, pp. 144
-
-
Herath, N.I.1
Spanevelb, M.D.2
Sabesan, S.3
|